Day 1 Program

Educational Session 4: Balancing Act—Hormone Replacement Therapy in Breast Cancer Care

Day 1: December 9, 2025

2:30 PM–4:15 PM CST

Hemisfair 1-2

Session Details

The session explores the evolution of evidence and guidelines for HRT, addressing myths, current recommendations from major societies, and tailored considerations for high-risk individuals, survivors, and various breast cancer subtypes.

Moderator

Tana Sanft, Yale Cancer Center, New Haven, CT

ED4-01

HRT and breast cancer: How history shaped fear and what comes next—Re-examining past research, debunking myths, and guiding future recommendations

Maryam Blm Lustberg, Yale School of Medicine, New Haven, CT

ED4-02

Navigating the latest HRT guidelines: What leading medical societies say—A comprehensive review of updated recommendations from major health organizations

Juliana M Kling, Mayo Clinic, Scottsdale, AZ

ED4-03

HRT across the breast cancer spectrum: Risks, benefits, and considerations—Exploring HRT use in high-risk individuals, survivors, and different breast cancer subtypes

Lisa Larkin, Ms.Medicine, Cincinnati, OH

Advocate

Thelma P. Brown, Thelma Brown (Individual), Birmingham, AL